In Silico Clinical-Trials: Advancing Validation for Regulatory Approval

The assesment of the safety and efficacy of medical devices can be time-consuming, expensive, and raise ethical concerns. Additionally, the high costs of innovation and lengthy development times may result in increased prices and unequal access for certain patient groups. In silico clinical trials (...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Leuchter Matthias, Supp Laura, Oldenburg Jan, Stiehm Michael, Schmitz Klaus-Peter, Borowski Finja
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	De Gruyter 2025-09-01
סדרה:	Current Directions in Biomedical Engineering
נושאים:	isct credibility fda medical device regulation regulatory affairs
גישה מקוונת:	https://doi.org/10.1515/cdbme-2025-0202
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!